OC-0544: Dose distributions optimized to microscopic disease probability distribution in breast conserving therapy  by Chen, W. et al.
S208  2nd ESTRO Forum 2013	
 
 Figure 1. ROC curves for TCP calculated using either average (dashed 
line) or patient specific (solid line) parameters α and Tpot. 
 
The dashed line corresponding to the TCP calculation based on 
average α and Tpot shows that the method has no power of 
discrimination with an area under the curve (AUC) of about 0.5. On 
the other hand, the ROC curve obtained based on patient specific α 
and Tpot (solid line) has an AUC of 0.7 and therefore this method does 
have an ability to distinguish between the two groups of patients 
presenting or not local control. The optimal threshold for TCP 
determined based on ROC analysis is 93% corresponding to a sensitivity 
of 66% and a specificity of 80%. 
Conclusions: This study shows that individual radiobiological 
parameters used for modelling TCP are better predictors of the 
radiation treatment outcome in individuals than literature-based 
average parameters.  
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Purpose/Objective: Residual microscopic disease (RMD) is considered 
to be the major cause of local recurrence in breast conserving 
therapy. Little knowledge, however, is available on how to optimally 
take the presence of RMD into consideration during radiotherapy. 
Traditionally, the whole breast is irradiated with/without a boost to 
the surgical bed. The purpose of this study was to optimize dose 
distributions to microscopic disease probability distribution obtained 
from detailed histopathology analyses. 
Materials and Methods: Population statistics of RMD were derived 
from 1818histopathology slides of 60 breast-cancer patients. The 
absolute quantity was fitted to a Poisson model and the relative ratio 
of RMD distribution was modeled with a half-Gaussian curve. A 
simulation framework was proposed. For simplicity,we assume a 
unifocal spherical tumor surgically removed from the center of a half 
spherical breast of 14 cm diameter with 5mm isotropic surgical 
margins.Perfectly spherical dose distributions with a 3.2 mm 
penumbra width were considered,while ignoring setup error and organ 
motion. A modified Webb-Nahum tumour control probability (TCP) 
model was adopted with parameters optimized to the histopathology 
data and the event data from the EORTC boost-vs-no-boost trial 
(uniform 50 Gy with/without 16 Gy at tumour bed) and the fifth cycle 
study of EBCTCG. Non-uniform dose distributions were optimized with 
TCPs equivalent to a uniform dose distribution of 50 Gy with and 
without a 16 Gy boost to a 3 cm diameter PTV. To that end, 10000 
virtual patients were sampled from the RMD probability distributions 
and the dose distributions were iteratively optimized by adding 1Gy at 
the radial distance with the largest TCP gain over the population of 
virtual patients. 
Results: The RMD volume per patient approximates 140 mm3on 
average and varies from 0 to 1076 mm3. One standard deviation(SD) of 
the half-Gaussian model was 6.3 mm (Figure 1-1, R-square 0.93). The 
radiosensitivity of disease cells in the TCP model is estimated to be 
0.056Gy-1 on average and with a Gaussian SD 0.009 Gy-1. The optimal 
dose distributions have a maximum dose 88 Gy at 1 mm to the surgical 
bed and the minimum dose 0 Gy (Figure 1-2). Our TCP model 
characteristics are shown by the relation curve between uniform dose 
and TCP assuming patients with average disease volume (Figure 2-1). 
The DVH within 25 mm to the surgical bed illustrates the possible 
reduction of high dose volume by the proposed dose distributions 
(Figure 2-2). 
 
  
Conclusions: Using a detailed microscopic disease distribution from 
histopathology analyses, the radiation treatment on the operated 
breast can be further optimized. The proposed dose distribution keeps 
the overall TCP the same but may largely reduce the high-radiation 
dose volume compared to the conventional treatment.  
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Purpose/Objective: Tumor hypoxia is associated with a poor outcome 
after radiotherapy. It can be assessed non-invasively by positron 
emission tomography (PET) using radiotracers that accumulate in 
poorly oxygenated tissue, such as 18F-Fluoromisonidazole (FMISO). 
However, only moderate correlations were reported between FMISO 
PET and direct PO2 measurements with oxygen sensing probes. 
Possible explanations were investigated in this study. Moreover, it was 
the purpose of this study to evaluate correlations between key figures 
of tumor oxygenation and different parameters that can be derived 
from FMISO PET imaging. 
Materials and Methods: Tumor tissue oxygenation was 
computationally simulated based on microvasculature images obtained 
from immunohistochemically stained tissue sections. Subsequently, 
the corresponding distribution-retention dynamics of FMISO was 
simulated. Sets of O2 and FMISO parameters were evaluated for 300 
distinct vessel configurations. As oxygenation key figures of a voxel, 
the vital hypoxic fraction (vHF) and the meanPO2 were chosen. For 
FMISO the PET voxel signal four hours after tracer injection (F4h) and 
the ratio between F4h and the mean signal during the first 15 min after 
injection (FH/P) were used. A correlation analysis was performed. This 
was followed by a receiver operating characteristic (ROC) analysis of 
how effectively hypoxia can be identified based on F4h and FH/P. 
Results: In hypoxic tissue F4h is well correlated with vHF (R2=0.90), 
while the correlation with meanPO2 is low (R2=0.22). A high nonlinear 
correlation was found between FH/P and meanPO2 (R2=0.99). The ROC 
analysis showed that tumor regions with a meanPO2 below 2.5 mmHg 
can be identified with high sensitivity and specificity by applying an 
appropriate threshold to FH/P (YI=sensitivity+specificity-1=0.94). The 
accuracy of F4h is considerably lower (YI=0.68). Both parameters are 
moderately effective in identifying critical PO2 levels on the 
microscopic length-scale (YI=0.63 and 0.60). 
Conclusions: A single static FMISO PET scan performed four hours 
after tracer injection appears to be suitable to estimate the vital 
hypoxic fraction in small tissue areas. A surrogate measure for the 
mean voxel PO2 might be provided by incorporating supplementary 
information from a second static FMISO PET scan performed instantly 
after tracer administration. Clinical investigations have to show which 
parameter is better suited for predicting radiotherapy outcome and, 
in a further step, might be used to prescribe a hypoxia-specific dose.  
   
